血小板含量对远半径骨折发生和预后的影响
Danyang Ding1, Hao Zhu2, Meiliang Zheng2
1Gastrointestinal Rehabilitation Center, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Shijingshan District, Beijing, P.R. China.
Medicine
|September 8, 2023
概括
较高的血小板和红细胞计数与偏距半径骨折 (DRF) 的风险增加有关. 血小板水平升高也与DRFs的恢复到复发时间缩短相关.
科学领域:
- 整形外科 整形外科 整形外科
- 血液学 血液学 血液学
- 流行病学 流行病学
背景情况:
- 距离半径骨折 (DRF) 越来越常见,但导致其发生的因素仍然不完全理解.
- 研究血液学参数可能会揭示对DRF病变发生和风险分层的新见解.
研究的目的:
- 检查特定血细胞计数 (白细胞,血红蛋白,血小板,红细胞) 与DRFs发生率之间的关联.
- 确定这些血液学参数是否影响DRF的风险和复发模式.
主要方法:
- 分析了123名DRF患者的队列.
- 测量了血细胞计数,并使用了统计分析,包括皮尔森千平方,斯皮尔曼相关性,单变量/多变量逻辑回归和多变量考克斯回归.
- 评估了血液学参数,患者人口统计和DRF结果之间的关系.
主要成果:
- 在血小板和红细胞水平和DRF发生之间发现了显著的相关性.
- 较高的血小板计数 (OR=6.344) 和红细胞计数 (OR=2.780) 独立地与DRFs的风险增加有关.
- 血小板数和性别是DRF从恢复到复发 (MTRR) 的时间的重要预测因素,血小板数较高表明MTRR较短.
结论:
- 血小板计数是远半径骨折发生和复发的重要危险因素.
- 升高的红细胞计数也可能导致DRF易感性.
- 血液学参数,特别是血小板,为评估DRF风险和预测恢复轨迹提供了潜在的生物标志物.
相关概念视频
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Fractures: Bone Repair
3.3K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.3K
Clot Retraction and Fibrinolysis
6.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
559
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
559


